MedPath

Evaluating the Safety and Efficacy of a Outpatient Appendectomy

Not Applicable
Conditions
Appendectomy
Appendicitis Acute
Registration Number
NCT04464382
Lead Sponsor
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Brief Summary

This study evaluates the Safety and Efficacy of a outpatient appendectomy. Half of participants will be perform the hospitalization, while the other half will undergo the outpatient appendectomy

Detailed Description

Acute appendicitis (AA) is one of the most common causes of acute abdomen and one of the most frequent diagnoses that require urgent surgery worldwide.

Many laparoscopic procedures are currently performed on an outpatient basis.Laparoscopic appendectomy, however, continues to require postoperative hospitalization averaging between 1 and 2 days, at most institutions.

At present ambulatory laparoscopic appendectomy (LA) are gained popularity due to the improved understanding of patient selection criteria, the application of enhanced recovery pathways, and the potential for improving healthcare resource utilization.

There are few studies about to compare the morbidity and readmission rates between ambulatory and conventional LA.

There is a lack of high-quality comparative studies making conclusive recommendations not possible at this time. Based on current data, ambulatory LA may be safe and feasible as compared with conventional LA.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
291
Inclusion Criteria
  • Patients over 14 years of age and who provide informed consent to participate in the study.
  • Patients with non complicated acute appendicitis requiring and urgent appendectomy (laparoscopic or minimum incision)
  • Negative appendicectomy.
Exclusion Criteria
  • Complicated acute appendicitis (abscess, perforated, necrosis and peritonitis)
  • Need to place intraoperative drainage.
  • Patients with American Society of Anesthesiologists (ASA) >IV.
  • Immunosuppressed patients.
  • Pregnant.
  • Possibility of inflammatory bowel disease.
  • No family support.
  • No informed consent signature.
  • Impossibility to comply with the established follow-up

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Rates of ambulatory appendectomy patients that have ambulatory surgery20 months

Analyze morbidity of appendectomy patients to determine the safety of ambulatory surgery

Rates of readmission of appendectomy patients that had ambulatory surgery20 months

Analyze rates of readmission of appendectomy patients to determine the safety of ambulatory surgery

Secondary Outcome Measures
NameTimeMethod
Prevalence of ambulatory appendectomy patients20 months

Measure the percentage of ambulatory surgery and uncomplicated acute appendicitis vs the percentage of ambulatory surgery in failure patients with the same pathology e.g.

* Uncontrolled abdominal pain with analgesia.

* Upper airway discomfort related to intubation that is not controlled with medication.

* Pain in the back or shoulders in relation to the pneumoperitoneum that are in patients with not controlled with the medication.

* Hemodynamically abnormal. Uncontrolled bleeding at the level of any of the wounds. Need for reoperation. Need to re-enter or consult the Emergency Service No spontaneous urination.

* Nausea / vomiting.

* Oral intolerance.

* No wandering.

* Insecurity or fear of the patient at discharge.

Media of time until the total incorporation to the activities of the daily life after appendectomy20 months

To value the time until the total incorporation to the activities of the daily life after appendectomy.

Rates of satisfaction20 months

Measure the degree of satisfaction of our patients with outpatient management after appendectomy, using a satisfaction questionnaire.

Costs of the outpatient regimen versus the hospitalization of patients20 months

Compare the costs of the outpatient regimen versus the hospitalization of patients with uncomplicated acute appendicitis (cost-minimization analysis).

Trial Locations

Locations (1)

Hospital Universitario Virgen Del Rocio

🇪🇸

Sevilla, Spain

Hospital Universitario Virgen Del Rocio
🇪🇸Sevilla, Spain
Pareja C Felipe, PhD
Contact
+34630962443
felipe.pareja67@gmail.com
Durán MC Virginia, MD
Contact
+34620073024
virginia.dm.87@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.